FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma. Huang J, Tsang WY, Fang XN, Zhang Y, et al. Cancer Res 2024;84:855-871.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang J, Tsang WY, Fang XN, Zhang Y, et al. FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma. Cancer Res 2024;84:855-871.
PMID: 38486485